CHICAGO--(BUSINESS WIRE)--CytoCore, Inc. (OTCBB:CYCR), the late-stage bio-scientific research company, has tendered payment of principal and accrued interest to its last senior debt holder, resulting in the reduction of approximately $1.7 million in liabilities.
